Henriksen Kim, Sørensen Mette G, Jensen Vicki K, Dziegiel Morten H, Nosjean Olivier, Karsdal Morten A
Nordic Bioscience A/S, Herlev Hovedgade 207, 2730 Herlev, Denmark.
Calcif Tissue Int. 2008 Sep;83(3):230-42. doi: 10.1007/s00223-008-9168-8. Epub 2008 Sep 12.
Osteoclasts possess a large amount of ion transporters, which participate in bone resorption; of these, the vacuolar-adenosine trisphosphatase (V-ATPase) and the chloride-proton antiporter ClC-7 acidify the resorption lacuna. However, whether other ion transporters participate in this process is currently not well understood. We used a battery of ion channel inhibitors, human osteoclasts, and their subcellular compartments to perform an unbiased analysis of the importance of the different ion transporters for acidification of the resorption lacuna in osteoclasts. CD14(+) monocytes from human peripheral blood were isolated, and mature osteoclasts were generated using RANKL and M-CSF. The human osteoclasts were (1) used for acridine orange assays for evaluation of lysosomal acidification, (2) used for bone resorption assays, (3) used for generation of osteoclasts membranes for acid influx experiments, or (4) lysed in trizol for mRNA isolation for Affymetrix array analysis. Inhibitors targeted toward most of the ion transporters showed low potency in the acidification-based assays, although some inhibitors, such as carbonic anhydrase II and the sodium-hydrogen exchanger (NHE) inhibitors, reduced resorption potently. In contrast, inhibitors targeted at V-ATPase and ClC-7 potently inhibited both acidification and resorption, as expected. We here show evidence that acidification of the resorption lacuna is mainly mediated by V-ATPase and ClC-7. Furthermore, a group of other ion transporters, including carbonic anhydrase II, the NHEs, and potassium-chloride cotransporters, are all involved in resorption but do not seem to directly be involved in acidification of the lysosomes.
破骨细胞拥有大量离子转运蛋白,它们参与骨吸收过程;其中,液泡型三磷酸腺苷酶(V-ATP酶)和氯离子-质子反向转运体ClC-7使吸收陷窝酸化。然而,目前对于其他离子转运蛋白是否参与这一过程尚不清楚。我们使用了一系列离子通道抑制剂、人破骨细胞及其亚细胞区室,对不同离子转运蛋白在破骨细胞吸收陷窝酸化中的重要性进行了无偏分析。从人外周血中分离出CD14(+)单核细胞,并使用RANKL和M-CSF生成成熟破骨细胞。这些人破骨细胞被用于:(1)吖啶橙试验以评估溶酶体酸化;(2)骨吸收试验;(3)生成破骨细胞膜用于酸内流实验;或(4)在Trizol中裂解以分离mRNA用于Affymetrix阵列分析。尽管一些抑制剂,如碳酸酐酶II和钠-氢交换体(NHE)抑制剂,能有效降低骨吸收,但针对大多数离子转运蛋白的抑制剂在基于酸化的试验中显示出低效性。相比之下,针对V-ATP酶和ClC-7的抑制剂如预期的那样有效抑制了酸化和骨吸收。我们在此证明,吸收陷窝的酸化主要由V-ATP酶和ClC-7介导。此外,包括碳酸酐酶II、NHEs和钾-氯共转运体在内的一组其他离子转运蛋白均参与骨吸收,但似乎并不直接参与溶酶体的酸化。